Marshall Wace’s LivaNova LIVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.65M | Sell |
26,023
-190,556
| -88% | -$12.3M | ﹤0.01% | 1885 |
|
|
2025
Q4 | $13.3M | Sell |
216,579
-186,204
| -46% | -$10.6M | 0.01% | 765 |
|
|
2025
Q3 | $21.1M | Sell |
402,783
-411,913
| -51% | -$20.7M | 0.02% | 634 |
|
|
2025
Q2 | $36.7M | Sell |
814,696
-293,341
| -26% | -$12.1M | 0.04% | 377 |
|
|
2025
Q1 | $43.5M | Buy |
1,108,037
+382,444
| +53% | +$17.2M | 0.06% | 312 |
|
|
2024
Q4 | $33.6M | Buy |
725,593
+239,227
| +49% | +$12.3M | 0.04% | 390 |
|
|
2024
Q3 | $25.6M | Sell |
486,366
-272
| -0.1% | -$13.5K | 0.03% | 437 |
|
|
2024
Q2 | $26.7M | Sell |
486,638
-225,194
| -32% | -$12.8M | 0.04% | 414 |
|
|
2024
Q1 | $39.8M | Sell |
711,832
-45,265
| -6% | -$2.35M | 0.06% | 299 |
|
|
2023
Q4 | $39.2M | Sell |
757,097
-133,506
| -15% | -$6.46M | 0.07% | 293 |
|
|
2023
Q3 | $47.1M | Buy |
890,603
+281,994
| +46% | +$15.5M | 0.1% | 217 |
|
|
2023
Q2 | $31.3M | Sell |
608,609
-3,835
| -0.6% | -$180K | 0.06% | 329 |
|
|
2023
Q1 | $26.7M | Sell |
612,444
-296,247
| -33% | -$15M | 0.06% | 364 |
|
|
2022
Q4 | $50.5M | Buy |
908,691
+447,934
| +97% | +$22.9M | 0.11% | 198 |
|
|
2022
Q3 | $23.4M | Sell |
460,757
-5,579
| -1% | -$331K | 0.05% | 406 |
|
|
2022
Q2 | $29.1M | Buy |
466,336
+4,607
| +1% | +$326K | 0.06% | 338 |
|
|
2022
Q1 | $37.8M | Hold |
461,729
| – | – | 0.07% | 300 |
|
|
2021
Q4 | $40.4M | Buy |
461,729
+368,955
| +398% | +$30.8M | 0.07% | 264 |
|
|
2021
Q3 | $7.35M | Buy |
+92,774
| New | +$7.62M | 0.03% | 734 |
|
|
2021
Q1 | – | Sell |
-45,567
| Closed | -$3.02M | – | 2696 |
|
|
2020
Q4 | $3.02M | Sell |
45,567
-8,982
| -16% | -$499K | 0.02% | 774 |
|
|
2020
Q3 | $2.47M | Sell |
54,549
-402,761
| -88% | -$19.5M | 0.02% | 755 |
|
|
2020
Q2 | $22M | Buy |
457,310
+405,152
| +777% | +$20.3M | 0.15% | 145 |
|
|
2020
Q1 | $2.36M | Sell |
52,158
-11,091
| -18% | -$718K | 0.02% | 577 |
|
|
2019
Q4 | $4.77M | Buy |
+63,249
| New | +$4.8M | 0.03% | 550 |
|
|
2019
Q1 | – | Sell |
-105,019
| Closed | -$9.61M | – | 1906 |
|
|
2018
Q4 | $9.61M | Sell |
105,019
-245,880
| -70% | -$26.4M | 0.1% | 255 |
|
|
2018
Q3 | $43.5M | Buy |
350,899
+204,684
| +140% | +$24.1M | 0.37% | 59 |
|
|
2018
Q2 | $14.6M | Sell |
146,215
-24,015
| -14% | -$2.18M | 0.22% | 134 |
|
|
2018
Q1 | $15.1M | Sell |
170,230
-216,655
| -56% | -$18.5M | 0.62% | 44 |
|
|
2017
Q4 | $30.9M | Buy |
386,885
+2,939
| +0.8% | +$233K | 1.3% | 19 |
|
|
2017
Q3 | $26.9M | Buy |
383,946
+2,402
| +0.6% | +$152K | 1.25% | 17 |
|
|
2017
Q2 | $23.3M | Sell |
381,544
-1,741
| -0.5% | -$98.5K | 1.03% | 25 |
|
|
2017
Q1 | $18.8M | Sell |
383,285
-19,361
| -5% | -$942K | 0.91% | 26 |
|
|
2016
Q4 | $18.1M | Sell |
402,646
-61,291
| -13% | -$3.01M | 0.12% | 210 |
|
|
2016
Q3 | $27.9M | Buy |
463,937
+148,808
| +47% | +$8.56M | 0.2% | 128 |
|
|
2016
Q2 | $15.8M | Buy |
315,129
+171,949
| +120% | +$8.69M | 0.13% | 175 |
|
|
2016
Q1 | $7.73M | Buy |
+143,180
| New | +$7.96M | 0.07% | 252 |
|
Other funds holding LIVN
Marshall Wace's LIVN Position: Q1 2026 in Review
Marshall Wace reduced its LivaNova (LIVN) stake by 88% in Q1 2026, selling an estimated $12.3M and leaving 26,023 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1885.
Marshall Wace first reported a position in LIVN in Q1 2016 and has held it in 36 quarters since. The position peaked at $50.5M in Q4 2022. 290 funds tracked by Wall St. Rank hold LIVN as of Q1 2026.
- Marshall Wace held 26,023 shares of LivaNova worth $1.65M as of Q1 2026.
- Marshall Wace sold 190,556 LivaNova shares in Q1 2026, an estimated $12.3M.
- LivaNova made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1885 holding.
- Marshall Wace first reported a position in LivaNova in Q1 2016 and has held it in 36 quarters since.
- Marshall Wace's LivaNova position peaked at $50.5M in Q4 2022.
- 290 funds tracked by Wall St. Rank held LivaNova as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.